Marshall Wace North America’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $1.52M | Buy |
+125,953
| New | +$1.52M | 0.01% | 777 |
|
|
2021
Q2 | – | Sell |
-7,175
| Closed | -$201K | – | 1478 |
|
|
2021
Q1 | $201K | Buy |
+7,175
| New | +$201K | ﹤0.01% | 1374 |
|
|
2020
Q3 | – | Sell |
-19,763
| Closed | -$1.02M | – | 1282 |
|
|
2020
Q2 | $1.02M | Buy |
+19,763
| New | +$1.02M | 0.01% | 754 |
|
|
2020
Q1 | – | Sell |
-23,750
| Closed | -$1.42M | – | 1334 |
|
|
2019
Q4 | $1.42M | Buy |
+23,750
| New | +$1.42M | 0.01% | 649 |
|
|
2019
Q2 | – | Sell |
-4,091
| Closed | -$164K | – | 1274 |
|
|
2019
Q1 | $164K | Buy |
+4,091
| New | +$164K | ﹤0.01% | 1028 |
|
|
2013
Q4 | $201K | Sell |
14,615
-891
| -6% | -$12.3K | ﹤0.01% | 642 |
|
|
2013
Q3 | $292K | Buy |
+15,506
| New | +$292K | 0.01% | 519 |
|